Insulet Corporation (PODD)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	206,300	120,000	62,900	600	4,600	16,800	34,600	44,600	16,800	-29,500	-30,500	8,900	6,800	28,900	18,100	5,100	11,600	16,500	17,400	14,300
Total stockholders’ equity	US$ in thousands	732,700	607,500	553,900	502,800	476,400	428,000	422,400	446,700	556,300	497,900	459,100	585,300	603,600	595,000	563,300	59,000	75,900	150,600	249,800	223,600
ROE		28.16%	19.75%	11.36%	0.12%	0.97%	3.93%	8.19%	9.98%	3.02%	-5.92%	-6.64%	1.52%	1.13%	4.86%	3.21%	8.64%	15.28%	10.96%	6.97%	6.40%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $206,300K ÷ $732,700K
= 28.16%

Insulet Corporation's return on equity (ROE) has shown a positive trend over the past few quarters. From a low of 0.12% in Q1 2023, the ROE has steadily increased to 28.16% in Q4 2023. This improvement indicates that the company has become more efficient in generating profits from shareholders' equity, reflecting positively on its overall financial performance and management effectiveness. The significant increase in ROE from Q1 2023 to Q4 2023 suggests that Insulet Corporation has been successful in leveraging its equity base to generate higher returns for its shareholders. It is important for investors and stakeholders to monitor ROE as it provides insights into a company's ability to generate profits from the capital invested by shareholders.